HOW TO EVALUATE A DIAGNOSTIC MARKER TEST - LESSONS FROM THE RISE AND FALL OF DEXAMETHASONE SUPPRESSION TEST

被引：112

作者：

NIERENBERG, AA

FEINSTEIN, AR

机构：

[1] YALE UNIV,SCH MED,ROBERT WOOD JOHNSON CLIN SCHOLAR PROGRAM,NEW HAVEN,CT 06510

[2] VET ADM MED CTR,COOPERAT STUDIES PROGRAM COORDINATING CTR,W HAVEN,CT 06516

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1988年 / 259卷 / 11期

关键词：

D O I：

10.1001/jama.259.11.1699

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1699 / 1702

页数：4

共 14 条

[1]

ARANA GW, 1985, ARCH GEN PSYCHIAT, V42, P1193

[2]

BALDESSARINI RJ, 1985, J CLIN PSYCHIAT, V46, P25

[3]

CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15

[4]

Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR, P597

[5] THE CLINICAL UTILITY OF THE DEXAMETHASONE SUPPRESSION TEST IN PSYCHIATRY - SUMMARY OF A "NATIONAL-INSTITUTE-OF-MENTAL-HEALTH WORKSHOP [J].

HIRSCHFELD, RMA ;

KOSLOW, SH ;

KUPFER, DJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (16) :2172-2174

[6]

INSEL TR, 1983, HOSP COMMUNITY PSYCH, V34, P1131

[7] DIAGNOSTIC UTILITY OF THE DEXAMETHASONE SUPPRESSION TEST [J].

KRISHNAN, KRR ;

DAVIDSON, JRT ;

RAYASAM, K ;

TANAS, KS ;

SHOPE, FS ;

PELTON, S .

BIOLOGICAL PSYCHIATRY, 1987, 22 (05) :618-628

[8] DEXAMETHASONE BIOAVAILABILITY - IMPLICATIONS FOR DST RESEARCH [J].

LOWY, MT ;

MELTZER, HY .

BIOLOGICAL PSYCHIATRY, 1987, 22 (03) :373-385

[9]

MULLEN PE, 1986, LANCET, V2, P1051

[10] PROBLEMS OF SPECTRUM AND BIAS IN EVALUATING EFFICACY OF DIAGNOSTIC TESTS [J].

RANSOHOFF, DF ;

FEINSTEIN, AR .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (17) :926-930

← 1 2 →